{"id":7960,"date":"2025-12-12T11:01:18","date_gmt":"2025-12-12T16:01:18","guid":{"rendered":"https:\/\/web.uri.edu\/pharmce\/?p=7960"},"modified":"2025-12-15T15:48:50","modified_gmt":"2025-12-15T20:48:50","slug":"mhc-pharmacy-law-course","status":"publish","type":"post","link":"https:\/\/web.uri.edu\/pharmce\/mhc-pharmacy-law-course\/","title":{"rendered":"MHC Pharmacy Law Course"},"content":{"rendered":"<div id=\"_e2v7kvkuq\" class=\"cl-wysiwyg-loading\" data-shortcode=\"%5Bcl-video%20alt%3D%22gout%22%20img%3D%22https%3A%2F%2Fweb.uri.edu%2Fpharmce%2Fwp-content%2Fuploads%2Fsites%2F1382%2Fgout.jpg%22%20id%3D%22%22%20vid%3D%22https%3A%2F%2Fyoutu.be%2FzmGT8Vgb5rM%22%20title%3D%22Pharmacotherapy%20in%20Gout%3A%20A%20Deep%20Dive%20into%20Established%20and%20Emerging%20Treatments%22%20excerpt%3D%22%22%20class%3D%22%22%5D\">\n<section class=\"cl-wrapper cl-video-wrapper\"><div class=\"cl-video  \"><div class=\"overlay\"><h1>MHC Pharmacy Law Course<\/h1><\/div><div class=\"poster\" id=\"wgjn22k6T7Y\" data-video=\"wgjn22k6T7Y\" data-platform=\"youtube\" data-showinfo=\"0\"><img decoding=\"async\" src=\"https:\/\/web.uri.edu\/pharmce\/wp-content\/uploads\/sites\/1382\/mhclaw.jpg\" alt=\"mhclaw\"\/><\/div><\/div><\/section><\/div>\n<div data-shortcode=\"%5Bcl-video%20alt%3D%22gout%22%20img%3D%22https%3A%2F%2Fweb.uri.edu%2Fpharmce%2Fwp-content%2Fuploads%2Fsites%2F1382%2Fgout.jpg%22%20id%3D%22%22%20vid%3D%22https%3A%2F%2Fyoutu.be%2FzmGT8Vgb5rM%22%20title%3D%22Pharmacotherapy%20in%20Gout%3A%20A%20Deep%20Dive%20into%20Established%20and%20Emerging%20Treatments%22%20excerpt%3D%22%22%20class%3D%22%22%5D\">&nbsp;<\/div>\n<section class=\"cl-wrapper cl-tabs-wrapper\"><div class=\"cl-tabs  \"><section class=\"cl-tab \"><h1>Overview<\/h1><\/p>\n<p>This home-study pharmacy law program provides an in-depth review of new and pending Massachusetts pharmacy legislation, along with recent federal regulatory updates related to the compounding of controlled substances. Originally presented as a live continuing education activity on December 2, 2025, this recorded session offers timely and practical guidance for pharmacists navigating an evolving legal and regulatory landscape.<\/p>\n<p>Participants will examine how state and federal laws shape pharmacy practice, define professional responsibilities, and influence day-to-day operational decision-making. The program highlights key regulatory principles governing compounding practices and the handling of controlled and other sensitive medications. In addition, learners will gain insight into the legislative and regulatory processes and explore strategies for effectively engaging with policy development that impacts the profession.<\/p>\n<p>This activity is approved for&nbsp;<strong>2.0 contact hours (0.2 CEUs) of pharmacy law continuing education home study credit<\/strong>.<\/p>\n<h3>Target Audience<\/h3>\n<p>Pharmacists in all practice settings.<\/p>\n<h3>Learning Objectives<\/h3>\n<p>Upon completion of this educational activity, pharmacists will be able to:<\/p>\n<p><strong>Dennis Lyons, BS, RPh<\/strong><br \/>\n<em><strong>2025 Massachusetts Legislative Update<\/strong><\/em><\/p>\n<ul>\n<li>Explain differences between legislation and regulation.<\/li>\n<li>Identify pending and past legislation impacting pharmacists in Massachusetts.<\/li>\n<li>Review existing laws and regulations that have changed the scope of pharmacist practice.<\/li>\n<li>Identify specific strategies and actions that can be taken by pharmacists to affect the legislative process.<\/li>\n<\/ul>\n<p><strong>Karla Palmer, J.D.<\/strong><br \/>\n<em><strong>Is the Future Formulated? Compounding of Controlled Substances in 2025<\/strong><\/em><\/p>\n<ul>\n<li>Explain the differences between FDCA Sections 503A and 503B as they relate to compounding with controlled substances.<\/li>\n<li>Define \u201canticipatory compounding\u201d as it is applied under current FDA and DEA guidance.<\/li>\n<li>Discuss the concept of constructive transfer of controlled substances and related regulatory implications.<\/li>\n<li>Describe the DEA\u2019s current requirements and monitoring expectations for compounding facilities handling controlled substances.<\/li>\n<\/ul>\n<h3><strong>Evaluation<\/strong><\/h3>\n<p>All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.<\/p>\n<h3><strong>Statement of Disclosure<\/strong><\/h3>\n<p>In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. No one involved in the planning of this program has any relevant financial relationships to disclose.<\/p>\n<p><\/section><section class=\"cl-tab \"><h1>Speakers<\/h1><\/p>\n<h3><strong>Dennis Lyons, B.S., R.Ph.<br \/>\n<\/strong><strong>DGL Healthcare Consulting<\/strong>&nbsp;<\/h3>\n<p><b><span data-contrast=\"none\">Dennis Lyons&nbsp;<\/span><\/b><span data-contrast=\"none\">is an accomplished expert in pharmacy healthcare law and regulations. He&nbsp;<\/span><span data-contrast=\"none\">owns and manages DGL Healthcare Consulting, where he provides strategic public policy and regulatory counsel and government relations support in the pharmacy and cannabis industries.&nbsp;&nbsp;Mr. Lyons has extensive experience in pharmacy and health care with over 40 years of experience in public,&nbsp;private&nbsp;and academic organizations at the senior management level.&nbsp;&nbsp;He regularly consults with boards, public officials, health care leaders, and professional associations on health care policy and legislative advocacy.&nbsp;<\/span><span data-contrast=\"auto\">Mr. Lyons currently&nbsp;represents&nbsp;the Massachusetts Independent Pharmacists Association (MIPA) providing legislative advocacy on such matters as PBM reform, Pharmacist Provider&nbsp;Status&nbsp;and compensation for pharmacy services. Mr. Lyons holds a B.S. from MCPHS University and is a registered pharmacist.&nbsp; He frequently lectures on&nbsp;the topic of regulatory&nbsp;affairs.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<h3><b><span data-contrast=\"auto\">Karla Palmer, J.D.<br \/>\n<\/span><\/b><b><span data-contrast=\"auto\">Director, Hyman, Phelps &amp; McNamara, PC<\/span><\/b><span data-ccp-props=\"{}\">&nbsp;<\/span><\/h3>\n<p><span data-contrast=\"auto\">As a litigator with over 33 years\u2019 experience, Karla advises clients throughout the<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">pharmaceutical supply chain \u2013 from manufacturers and distributors to outsourcing facilities,<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">pharmacies and doctors \u2013 on a range of legal and regulatory issues. These matters include DEA<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">and FDA regulations and guidance, government inspections and investigations, Form 483<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">observations, warning letters, consent decrees, and administrative and federal proceedings. She<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">represents&nbsp;entities and individuals in matters involving their DEA registration, including<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">investigations, orders to show cause, immediate suspension matters,&nbsp;hearings&nbsp;and federal appeals<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">of&nbsp;the same. Karla is a nationally recognized leader in the compounding space, both for Section<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">503A and 503B facilities. She regularly&nbsp;counsels&nbsp;clients on all aspects of compliance with state<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">and federal statutes,&nbsp;regulations&nbsp;and guidance. Karla has written about and addressed industry<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">audiences across the country on FDA and compliance matters, including all aspects of the<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">passage and implementation of the 2013 Drug Quality and Security Act including both<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><span data-contrast=\"auto\">compounding and supply chain issues,&nbsp;its guidance&nbsp;documents, and implementing regulations.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><\/section><\/p>\n<p><section class=\"cl-tab \"><h1>CE Credit<\/h1><\/p>\n<div id=\"_t7rrurbva\" class=\"cl-wysiwyg-loading\" data-shortcode=\"%5Bcl-boxout%20title%3D%22The%20accreditation%20service%20fee%20for%20this%20program%20is%20%247.00%22%20class%3D%22%22%20float%3D%22%22%5D%5B%2Fcl-boxout%5D\">\n<section class=\"cl-wrapper cl-boxout-wrapper\"><div class=\"cl-boxout  \"><h1>The accreditation service fee for this program is $20.00<\/h1><p><\/p><\/div><\/section><\/div>\n<div data-shortcode=\"%5Bcl-boxout%20title%3D%22The%20accreditation%20service%20fee%20for%20this%20program%20is%20%247.00%22%20class%3D%22%22%20float%3D%22%22%5D%5B%2Fcl-boxout%5D\">&nbsp;<\/div>\n<h2 id=\"_71dxafsx9\" class=\"cl-wysiwyg-loading\" data-shortcode=\"%5Bcl-button%20link%3D%22http%3A%2F%2Fwww.uripharmacycpd.org%22%20text%3D%22Register%20to%20Claim%20CE%20Credit%22%20tooltip%3D%22%22%20class%3D%22%22%20style%3D%22prominent%22%5D\">Steps to complete the program and claim credit:<\/h2>\n<ol>\n<li>Watch the video at the top of this page.<\/li>\n<li>Login or create an account in LUX LMS, URI\u2019s learning management and CE reporting system, using your email address and professional license number. Complete all required account set up fields to ensure accurate CE reporting.<\/li>\n<li>Select \u201cAvailable On-Line Activities\u201d or \u201cHome Study Programs\u201d to find the educational activity.<\/li>\n<li>Select Take Post-Test and proceed to secure online payment (Visa, MC, AMEX, Discover and Electronic Checks are accepted).<\/li>\n<\/ol>\n<div id=\"_qork71hun\" class=\"cl-wysiwyg-loading\" data-shortcode=\"%5Bcl-button%20link%3D%22http%3A%2F%2Fwww.uripharmacycpd.org%22%20text%3D%22Register%20to%20Claim%20CE%20Credit%22%20tooltip%3D%22%22%20class%3D%22%22%20style%3D%22prominent%22%5D\"><a class=\"cl-button   prominent\" href=\"http:\/\/www.uripharmacycpd.org\" title=\"\">Register to Claim CE Credit<\/a><\/div>\n<p>&nbsp;<\/p>\n<h3>Requirements for Credit<\/h3>\n<p>Completion of the online educational activity and a program evaluation are required to earn credit. No partial credit is available for this program. Evaluations must be completed at <a href=\"http:\/\/www.uripharmacycpd.org\">www.uripharmacycpd.org<\/a> within 60 days. This program offers one contact hour (0.20 ceus) of Immunization CE for Pharmacists.<\/p>\n<h3>&nbsp;<\/h3>\n<h3><strong>Pharmacy Accreditation Statement<\/strong><\/h3>\n<p style=\"text-align: left\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-6606 alignleft\" src=\"https:\/\/web.uri.edu\/pharmce\/wp-content\/uploads\/sites\/1382\/acpelogo-288x300.jpg\" alt=\"\" width=\"152\" height=\"170\"><\/p>\n<p style=\"text-align: left\">The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program will provide 2.0 Contact Hour (0.2 CEU) for pharmacists. <span class=\"TextRun SCXW107029484 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW107029484 BCX8\">UAN<\/span><span class=\"NormalTextRun SCXW107029484 BCX8\">: 0060-9999-25-055-H03-P<\/span><\/span><\/p>\n<p><span class=\"NormalTextRun SCXW9573119 BCX8\">Release Date: <\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">December 15<\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">, <\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW9573119 BCX8\">202<\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW9573119 BCX8\">5<\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">Expiration Date: <\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">December 15,<\/span><span class=\"NormalTextRun SCXW9573119 BCX8\"> 202<\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">6<\/span><span class=\"NormalTextRun SCXW9573119 BCX8\">.<\/span><\/p>\n<p><\/section><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>This\u00a0MHC\u00a0program offers an overview of how laws and regulations shape pharmacy\u00a0practice\u00a0and influence professional responsibilities. Participants will explore how evolving policies affect the scope of practice and operational expectations for pharmacists. The session also highlights key regulatory concepts that guide compounding and the handling of sensitive medications. Finally, attendees will gain strategies to effectively engage in and influence the legislative and regulatory process.<\/p>\n<h5>This activity is available to access free of charge.<\/h5>\n<p><i>If you wish to claim CE credit for participation there is a $20.00 accreditation service fee which is paid when you register for the course.<\/I><\/p>\n","protected":false},"author":639,"featured_media":7963,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[10],"tags":[22],"class_list":["post-7960","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-homestudy","tag-pharmacy-ce-accredited"],"acf":[],"_links":{"self":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts\/7960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/users\/639"}],"replies":[{"embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/comments?post=7960"}],"version-history":[{"count":5,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts\/7960\/revisions"}],"predecessor-version":[{"id":7983,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/posts\/7960\/revisions\/7983"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/media\/7963"}],"wp:attachment":[{"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/media?parent=7960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/categories?post=7960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.uri.edu\/pharmce\/wp-json\/wp\/v2\/tags?post=7960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}